Atlas Trials

A Phase 2 Study to Evaluate Immune Responses of FluMist®

Clinical trial NCT00461981 · COMPLETED

Trial details

NCT number
NCT00461981
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza Vaccine
Start date
2007-05-01
Primary completion
2007-12-01
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.